Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

High Sheriff of Oxfordshire Imam Monawar Hussain presents the Outstanding Technical Leadership: Therapeutic Innovation award to Adrian Hill

Part of the High Sheriff of Oxfordshire’s Covid Heroes programme, the awards presented the Institute with the Outstanding Technical Leadership: Therapeutic Innovation honour. This was in recognition of its incredible work to develop, pilot, organise clinical trials for, scale-up and roll-out – in partnership with AstraZeneca – the COVID-19 vaccine in such a short space of time, saving millions of lives across the world.

Professor Adrian Hill KBE, Director of the Jenner Institute & Lakshmi Mittal & Family Professor of Vaccinology who received the award on the Institute’s behalf, said: ‘The COVID-19 vaccine response provides an excellent illustration of the strong links between academia and industry in the UK, with a vaccine candidate from the Jenner Institute at Oxford moving rapidly to many UK industrial partners in early 2021 and then onto many more manufacturing sites internationally – providing over 2 billion doses for 180 countries.’

Read the full story on the University of Oxford website

Similar stories

Attention and memory deficits persist for months after recovery from mild Covid

Researchers from Oxford’s Department of Experimental Psychology and Nuffield Department of Clinical Neurosciences have shown that people who have had Covid but don’t complain of long Covid symptoms in daily life nevertheless can show degraded attention and memory for up to 6-9 months.

New book expands the horizons of brain research

A pioneering book from Professor Zoltán Molnár and Yale Professors Tamas Horvath and Joy Hirsch to be released on 1 February 2022 addresses the fundamental relationship between the body, brain and behaviour.

New research sheds light on how ultrasound could be used to treat psychiatric disorders

A new study in macaque monkeys has shed light on which parts of the brain support credit assignment processes (how the brain links outcomes with its decisions) and, for the first time, how low-intensity transcranial ultrasound stimulation (TUS) can modulate both brain activity and behaviours related to these decision-making and learning processes.

Dramatic fall in hospital admissions for child infections since start of Covid-19 pandemic

Since the onset of the Covid-19 pandemic, there have been dramatic reductions in hospital admissions for common and severe childhood infections in England, most likely due to social distancing measures, school and workplace closures, and travel restrictions, finds a study published by The BMJ today.

Rosalind Franklin Institute and Pharmacology announce strategic partnership in Next Generation Chemistry

The Rosalind Franklin Institute and the University of Oxford’s Department of Pharmacology have entered into a strategic partnership for Next Generation Chemistry.

Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity

Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.